Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
Open Access
- 18 April 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1198
Abstract
This study aimed to determine the size and distribution of LDL and HDL particles in North African acute coronary syndrome (ACS) patients and to compare the level of small dense LDL (sdLDL) to other markers used in cardiovascular risk prediction. Methods: A total of 205 ACS patients and 100 healthy control subjects were enrolled. LDL particle size and LDL and HDL subclass distributions were measured using Quantimetric Lipoprint® linear polyacrylamide gel electrophoresis. Lipid ratios (total cholesterol, LDL cholesterol, non-HDL cholesterol, and HDL cholesterol) were determined to calculate the atherogenic index of plasma (AIP), the atherogenic coefficient (AC), Castelli’s Risk-I (CR-I), and Castelli’s Risk-II (CR-II). Receiver operating characteristic (ROC) curve analyses and area under the curve (AUC) were used to assess the predictive value of sdLDL as a marker for cardiovascular disease. Results: The ACS patients, compared to the healthy control subjects, displayed an alteration of LDL particle distribution, with a significant increase in sdLDL serum concentrations (0.303 ± 0.478 mmol/L vs. 0.0225 ± 0.043 mmol/L, respectively, p < 0.001). The sdLDL levels had a high discrimination accuracy [AUC = 0.847 ± 0.0353 (95% CI 0.778 to 0.916, p < 0.0001)]. The best predictive cutoff value of ACS determined with the maximum Youden index (J) [(sensitivity + specificity) − 1 = 0.60] was 0.038 mmol/L. A Spearman correlation analysis showed that sdLDL levels were moderately but significantly and positively correlated with AC and CR-I (r = 0.37, p < 0.001) and weakly but significantly correlated with PAI and CR-II; r = 0.32 (p < 0.001) and r = 0.30 (p < 0.008), respectively. The subclass distribution of HDL particles from ACS patients was also altered, with a decrease in large HDL particles and an increase in small HDL particles compared to HDL from healthy control subjects. Conclusion: Due to their high atherogenicity, sdLDL levels could be used as a valuable marker for the prediction cardiovascular events.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP-89912, 201809PJT)
This publication has 35 references indexed in Scilit:
- Hypertriglyceridemia is a Major Factor Associated With Elevated Levels of Small Dense LDL Cholesterol in Patients With Metabolic SyndromeAnnals of Laboratory Medicine, 2015
- New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Susceptibility of LDL and its subfractions to glycationCurrent Opinion in Lipidology, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Small Dense LDL Cholesterol and Coronary Heart Disease: Results from the Framingham Offspring StudyClinical Chemistry, 2010
- Comparability of methods for LDL subfraction determination: A systematic reviewAtherosclerosis, 2009
- Plasma preβ1-HDL level is elevated in unstable angina pectorisAtherosclerosis, 2009
- Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosisAtherosclerosis, 2009
- LDL particle size distribution. Results from the Framingham Offspring Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Circulation, 1990